ASMS 2024, a main event for the mass spectrometry community, showcased the latest advancements in mass spectrometry and fostered important collaborations in the field of metabolomics.
All posts from
Treatment of non-alcoholic fatty liver disease (NAFLD) as a chemopreventive strategy for other chronic disease: a metabolomics perspective
NAFLD is a key player in other chronic diseases – both as a prevalent comorbidity and a contributing factor. Does this mean that treating NAFLD could prevent those conditions?
Metabolomics – (not) a game changer in toxicology?
Why is metabolomics a game-changer in toxicology? We think so, but why are toxicologists split on this question?
ICYMI – Recap from “Pan-cohort studies – the future of population health” symposium
With more than 20 hours of cutting-edge science in the rearview mirror, it’s time to reflect on our recent “Pan-cohort studies – The future of population health” event.
Which sample matrix should I use for my metabolomics study?
While there’s no single correct approach to figuring out your sample matrix, there certainly are things that could be done wrong. Here, we dive into some of the advantages and advantages of the sample matrices you might consider for you metabolomics study.
Adverse effects in immunotherapy
Only 20–30 % of patients experience a long-term benefit from immunotherapy, but the high rate of adverse events in immunotherapies is also a matter of intense research and scientific debate
Therapy resistance: could metabolomic biomarkers remove this major roadblock to successful pharmaceutical research and development programs?
Pharmaceutical therapies have created huge benefits for society in expanding healthy life span
The 8th Munich Metabolomics Symposium
Recap of the 8th Munich Metabolomics Symposium, November 12th, 2021
Targeted metabolomics as a tool to monitor sow and piglet health in swine breeding
Metabolomics helps detect potentially catastrophic health issues in pregnant sows and weaning piglets
Cholesterol metabolism in Alzheimer’s disease
Brain cholesterol metabolism is altered in Alzheimer’s Disease.
Metabolic effects of anti-TNF α therapy
Anti-TNF α therapy in Crohn´s Disease improves liver steatosis through changes in gut bacteria and triglycerides.
How different sports shape the blood metabolome
The metabolome differentiates athlete phenotypes
Metabolism of fatty liver disease and the impact of therapy
New study demonstrates the power of metabolomics in boosting our understanding of fatty liver disease – and possible treatments. Obeticholic acid reverses metabolic changes in NASH.
Metabolomics can help identify root causes of hypertension
Targeted metabolomics discriminates between primary and endocrine hypertension.
Defining the biochemistry of obesity
Increasing degree of metabolic dysregulation visible in the blood metabolome depending on the degree of obesity.
Metabolomics reveals link between adipose tissue and severe COVID-19
A lipid signature is associated with disease severity and inflammatory status in patients with COVID-19.
7 tips to make your first metabolomics project successful (with story)
To obtain optimal results from your metabolomics project you might want to answer these seven questions to increase your success.
Commentary – A current view on steroid hormones
Although they are only present in low concentration in our bodies, steroid hormones play a crucial role in a variety of biological processes. This article reflects recent studies on the topic.
Pan-Cohort Metabolomics – The future of population health
Epidemiological research contributes greatly to our understanding of what constitutes healthy aging. Cohort studies hold the key to identifying risk factors for common diseases. Metabolomics is a valuable tool to make cohort studies successful.
Metabolomic profiling and the prediction of 90-day mortality
Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP)
COVID-19 – Metabolomics prediction of long-term outcome
Those who recover from COVID-19, especially after severe cases, have experienced a great deal of pain and discomfort. However, because of potential multi-organ injuries that more closely resemble the situation after sepsis rather than recovery from an Influenza virus infection, COVID-19 survivors often experience long-term consequences of the infection.
Metabolomics and response to SARS-CoV-2 vaccination
While vaccine development has been faster than for any previous emerging infectious disease, the next big challenge will be the logistics of producing and distributing hundreds of millions of doses.
Metabolic interaction of COVID-19 and metabolic diseases
It is well established that within the context of infectious diseases, both host and pathogen impact each other’s metabolism. Viral diseases, such as COVID-19, perfectly exemplify this, as the virus hijacks host cells in order to survive and replicate.
Is Alzheimer’s a metabolic disease?
Alzheimer’s disease (AD) has many facets. Metabolomics supports Alzheimer’s early diagnosis and research on the treatment of AD.
Therapy response monitoring in infectious diseases
Monitoring COVID-19 patient’s pathophysiology using metabolomics can lead to early detection of therapy response, opening an avenue to precision medicine.
Metabolomics and COVID-19
Monitoring COVID-19 patient’s pathophysiology might lead to early detection of therapy response, opening an avenue to precision medicine. Metabolomics is a tool to support these efforts.
Upcoming events
2023©biocrates life sciences ag
All rights reserved
Privacy & Policy
Imprint
Terms & Conditions
Products
Targeted profiling kits
MxP® Quant 500
MxP® Quant HR Xpress™
AbsoluteIDQ® p400
HR AbsoluteIDQ® p180
Pathway specific kits
AbsoluteIDQ® Stero17
AbsoluteIDQ® Bile Acids
All biocrates products and services are intended
For research use only | not for use in diagnostic procedures.